cd160 by55 Search Results


anti cd160 mab  (Sino Biological)
90
Sino Biological anti cd160 mab
Anti Cd160 Mab, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160+by55/CD160+%2F+NK1+%2F+BY55+Antibody%2C+Rabbit+MAb/us10975159-587-29-52
Average 90 stars, based on 1 article reviews
anti cd160 mab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cd160 by55 polyclonal antibody, abby fluor 488 conjugated  (Bioss)
N/A
CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of
   Buy from Supplier
cd160  (OriGene)
91
OriGene cd160
Cd160, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160+by55/CD160+(NM_007053)+Human+Tagged+ORF+Clone/pm37500142-58-7-8
Average 91 stars, based on 1 article reviews
cd160 - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
af488-il17a  (Becton Dickinson)
90
Becton Dickinson af488-il17a
Af488 Il17a, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160+by55/anti+cd160+af488+by55/pmc06872777-73-6-9
Average 90 stars, based on 1 article reviews
af488-il17a - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cd160-pe clone by55 antibody  (Immunotec inc)
90
Immunotec inc cd160-pe clone by55 antibody
MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of <t>CD160</t> of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).
Cd160 Pe Clone By55 Antibody, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd160+by55/anti+cd160+mab+by55/pmc04314455-72-25-30
Average 90 stars, based on 1 article reviews
cd160-pe clone by55 antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
recombinant human cd160/by55 protein (aa 1-158  (Elabscience Biotechnology)
N/A
CD160 antigen, also known as Natural killer cell receptor BY55 and CD160, is a cell membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. CD160 is a GPI-anchored lymphocyte surface receptor in which expression is
   Buy from Supplier
human cd160/nk1/by55 gene orf cdna clone expression plasmid, c-myc tag  (Sino Biological)
N/A
Full length Clone DNA of Human CD160 molecule with C terminal Myc tag.
   Buy from Supplier
mouse cd160/nk1/by55 gene orf cdna clone expression plasmid, n-his tag  (Sino Biological)
N/A
Full length Clone DNA of Mouse CD160 antigen with N terminal His tag.
   Buy from Supplier
mouse cd160/nk1/by55 gene orf cdna clone expression plasmid, n-ha tag  (Sino Biological)
N/A
Full length Clone DNA of Mouse CD160 antigen with N terminal HA tag.
   Buy from Supplier
rhesus cd160/nk1/by55 gene orf cdna clone expression plasmid  (Sino Biological)
N/A
Full length Clone DNA of Rhesus CD160 molecule.
   Buy from Supplier
cd160 by55 polyclonal antibody, abby fluor 647 conjugated  (Bioss)
N/A
CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of
   Buy from Supplier
cd160 by55 polyclonal antibody, abby fluor 680 conjugated  (Bioss)
N/A
CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of
   Buy from Supplier

Image Search Results


MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of CD160 of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).

Journal: Blood Cancer Journal

Article Title: Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

doi: 10.1038/bcj.2014.92

Figure Lengend Snippet: MRD detection by CD160FCA and correlation with PCR in the pilot cohort. ( a ) The theoretical MRD expression (calculated, x axis) is plotted against the observed MRD expression (actual analyzed MRD analysis, y axis) by CD160FCA. The results are the percentage expression of CD160 of the total leukocyte population. The comparative RT-PCR results are demonstrated at the top of the graph above the corresponding dilution. The R 2 linear regression value for observed expression vs theoretical expression was R 2 =0.98. ( b ) Separation of MRD-positive and MRD-negative populations based on CD160FCA assessment ( P =0.01). ( c ) MRD assessment in paired peripheral blood and bone marrow CLL cells as determined by the CD160FCA ( n =47), irrespective of the treatment regimen (Spearman Rank R =0.87, P <0.0001).

Article Snippet: The CD160FCA incorporates CD2-FITC (Clone S5.2), CD5-APC (Clone L17F12), CD19-PerCP cy5.5 (Clone SJ25C1), CD23-APC (Clone EBVCS-5) and CD45 V500 (Clone Hi30) (BD Biosciences, Oxford, UK); CD160-PE (Clone BY55; IgM isotype; Immunotech, Beckman Coulter, Marseilles, France).

Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction

MRD detection by CD160FCA vs International Standardized Protocols in the validation cohort. ( a ) Comparative assessment of CD160FCA MRD positivity as a percentage of total leucocytes against the ISA methodology ( n =48 samples, P <0.001, R =0.91). ( b ) MRD-positive and -negative cohorts based on the median fluorescence intensity (MFI) of the CD2 neg /CD5 + /CD19 + /CD23 + /CD160 + population.

Journal: Blood Cancer Journal

Article Title: Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

doi: 10.1038/bcj.2014.92

Figure Lengend Snippet: MRD detection by CD160FCA vs International Standardized Protocols in the validation cohort. ( a ) Comparative assessment of CD160FCA MRD positivity as a percentage of total leucocytes against the ISA methodology ( n =48 samples, P <0.001, R =0.91). ( b ) MRD-positive and -negative cohorts based on the median fluorescence intensity (MFI) of the CD2 neg /CD5 + /CD19 + /CD23 + /CD160 + population.

Article Snippet: The CD160FCA incorporates CD2-FITC (Clone S5.2), CD5-APC (Clone L17F12), CD19-PerCP cy5.5 (Clone SJ25C1), CD23-APC (Clone EBVCS-5) and CD45 V500 (Clone Hi30) (BD Biosciences, Oxford, UK); CD160-PE (Clone BY55; IgM isotype; Immunotech, Beckman Coulter, Marseilles, France).

Techniques: Biomarker Discovery, Fluorescence